Piper Sandler Reiterates Overweight Rating on Arrowhead Pharma (ARWR)
Go back to Piper Sandler Reiterates Overweight Rating on Arrowhead Pharma (ARWR)| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 90.38 +1.14 (1.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $89.24 | 52 Week High | $8.22 | |||
| Open | $89.09 | 52 Week Low | $3.07 | |||
| Day High | $90.41 | P/E | N/A | |||
| Day Low | $88.72 | EPS | $-1.30 | |||
| Volume | 38,116 | |||||
